BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30679590)

  • 21. Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells.
    Rozovski U; Harris DM; Li P; Liu Z; Jain P; Veletic I; Ferrajoli A; Burger J; Thompson P; Jain N; Wierda W; Keating MJ; Estrov Z
    Int J Cancer; 2017 Nov; 141(10):2076-2081. PubMed ID: 28722170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition.
    Slinger E; Thijssen R; Kater AP; Eldering E
    Leukemia; 2017 Dec; 31(12):2601-2607. PubMed ID: 28462919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells.
    Guarini A; Chiaretti S; Tavolaro S; Maggio R; Peragine N; Citarella F; Ricciardi MR; Santangelo S; Marinelli M; De Propris MS; Messina M; Mauro FR; Del Giudice I; Foà R
    Blood; 2008 Aug; 112(3):782-92. PubMed ID: 18487510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
    Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
    Leukemia; 2011 May; 25(5):828-37. PubMed ID: 21372840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.
    Benkisser-Petersen M; Buchner M; Dörffel A; Dühren-von-Minden M; Claus R; Kläsener K; Leberecht K; Burger M; Dierks C; Jumaa H; Malavasi F; Reth M; Veelken H; Duyster J; Zirlik K
    PLoS One; 2016; 11(12):e0169159. PubMed ID: 28036404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.
    Nichols EM; Jones R; Watson R; Pepper CJ; Fegan C; Marchbank KJ
    Oncotarget; 2015 Oct; 6(32):32669-80. PubMed ID: 26452134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies.
    Leveille E; Chan LN; Mirza AS; Kume K; Müschen M
    Cell Signal; 2022 Jun; 94():110331. PubMed ID: 35398488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
    Seda V; Mraz M
    Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
    Haerzschel A; Catusse J; Hutterer E; Paunovic M; Zirlik K; Eibel H; Krenn PW; Hartmann TN; Burger M
    Ann Hematol; 2016 Dec; 95(12):1979-1988. PubMed ID: 27542958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors.
    Kofler DM; Büning H; Mayr C; Bund D; Baumert J; Hallek M; Wendtner CM
    Gene Ther; 2004 Sep; 11(18):1416-24. PubMed ID: 15269708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2.
    von Wenserski L; Schultheiß C; Bolz S; Schliffke S; Simnica D; Willscher E; Gerull H; Wolters-Eisfeld G; Riecken K; Fehse B; Altfeld M; Nollau P; Binder M
    Leukemia; 2021 Apr; 35(4):1073-1086. PubMed ID: 32826957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deregulation of Ikaros expression in B-1 cells: New insights in the malignant transformation to chronic lymphocytic leukemia.
    Oliveira VC; Lacerda MP; Moraes BBM; Gomes CP; Maricato JT; Souza OF; Schenkman S; Pesquero JB; Moretti NS; Rodrigues CA; Popi AF
    J Leukoc Biol; 2019 Sep; 106(3):581-594. PubMed ID: 31299112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal Syk protein level but abnormal tyrosine phosphorylation in B-CLL cells.
    Semichon M; Merle-Béral H; Lang V; Bismuth G
    Leukemia; 1997 Nov; 11(11):1921-8. PubMed ID: 9369427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between ZAP-70, phospho-ZAP-70, and phospho-Syk expression in leukemic cells from patients with CLL.
    Kaplan D; Meyerson HJ; Li X; Drasny C; Liu F; Costaldi M; Barr P; Lazarus HM
    Cytometry B Clin Cytom; 2010 Mar; 78(2):115-22. PubMed ID: 20014315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells.
    Rozovski U; Wu JY; Harris DM; Liu Z; Li P; Hazan-Halevy I; Ferrajoli A; Burger JA; O'Brien S; Jain N; Verstovsek S; Wierda WG; Keating MJ; Estrov Z
    Blood; 2014 Jun; 123(24):3797-802. PubMed ID: 24778152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease.
    Vlad A; Deglesne PA; Letestu R; Saint-Georges S; Chevallier N; Baran-Marszak F; Varin-Blank N; Ajchenbaum-Cymbalista F; Ledoux D
    Cancer Res; 2009 Aug; 69(16):6387-95. PubMed ID: 19654311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients.
    Nédellec S; Renaudineau Y; Bordron A; Berthou C; Porakishvili N; Lydyard PM; Pers JO; Youinou P
    J Immunol; 2005 Mar; 174(6):3749-56. PubMed ID: 15749915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.
    Wolska A; Cebula-Obrzut B; Smolewski P; Robak T
    Leuk Lymphoma; 2013 Jun; 54(6):1268-78. PubMed ID: 23078646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.
    Burger JA; Quiroga MP; Hartmann E; Bürkle A; Wierda WG; Keating MJ; Rosenwald A
    Blood; 2009 Mar; 113(13):3050-8. PubMed ID: 19074730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adhesion of ZAP-70+ chronic lymphocytic leukemia cells to stromal cells is enhanced by cytokines and blocked by inhibitors of the PI3-kinase pathway.
    Lafarge ST; Johnston JB; Gibson SB; Marshall AJ
    Leuk Res; 2014 Jan; 38(1):109-15. PubMed ID: 23981382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.